Stallion Laboratories Pvt Ltd — Captopril Exporter Profile
Indian Pharmaceutical Exporter · #6 for Captopril · $189.4K export value · DGFT Verified
Stallion Laboratories Pvt Ltd is the #6 Indian exporter of Captopril with $189.4K in export value and 19 verified shipments. Stallion Laboratories Pvt Ltd holds a 1.5% market share in Captopril exports across 3 countries.
Stallion Laboratories Pvt Ltd — Captopril Export Profile: Buyers & Destinations
Where Does Stallion Laboratories Pvt Ltd Export Captopril?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $162.6K | 9 | 73.3% |
| PHILIPPINES | $55.1K | 10 | 24.8% |
| BELIZE | $3.8K | 2 | 1.7% |
| NETHERLANDS | $477 | 1 | 0.2% |
Stallion Laboratories Pvt Ltd exports Captopril to 4 countries. The largest destination is SOUTH AFRICA accounting for 73.3% of Stallion Laboratories Pvt Ltd's Captopril shipments, followed by PHILIPPINES (24.8%) and BELIZE (1.7%). These destinations reflect Stallion Laboratories Pvt Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Captopril from Stallion Laboratories Pvt Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE | SOUTH AFRICA | $50.0K | 1 |
| TO THE ORDER OF. | PHILIPPINES | $38.0K | 9 |
| TO THE ORDER OF, | PHILIPPINES | $18.6K | 2 |
| PHARMACEUTICAL WAREHOUSING INC | NETHERLANDS | $477 | 1 |
Stallion Laboratories Pvt Ltd supplies Captopril to 4 buyers globally. The largest buyer is TO THE (SOUTH AFRICA), followed by TO THE ORDER OF. (PHILIPPINES) and TO THE ORDER OF, (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Captopril Export Value and How Much Does Stallion Laboratories Pvt Ltd Contribute?
India exported $4.5M worth of Captopril through 517 shipments from 109 suppliers to 63 countries, serving 170 buyers globally. Stallion Laboratories Pvt Ltd contributes $189.4K to this total, accounting for 1.5% of India's Captopril exports. Stallion Laboratories Pvt Ltd ships Captopril to 4 countries through 4 buyers.
What Is the Average Shipment Value for Stallion Laboratories Pvt Ltd's Captopril Exports?
Stallion Laboratories Pvt Ltd's average Captopril shipment value is $10.0K per consignment, based on 19 shipments totaling $189.4K. The largest destination is SOUTH AFRICA (73.3% of Stallion Laboratories Pvt Ltd's Captopril exports).
How Does Stallion Laboratories Pvt Ltd Compare to Other Indian Captopril Exporters?
Stallion Laboratories Pvt Ltd ranks #6 among 109 Indian Captopril exporters with a 1.5% market share. The top 3 exporters are AJANTA PHARMA LIMITED ($1.3M), LINCOLN PHARMACEUTICALS LTD ($1.0M), GRACURE PHARMACEUTICALS LIMITED ($686.2K). Stallion Laboratories Pvt Ltd processed 19 shipments to 3 destination countries.
What Captopril Formulations Does Stallion Laboratories Pvt Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICALS DRUGS & MEDICINES SATCAPTO-25 (CAPTOPRIL TABLETS USP 25 MG)AS PER INVOICE) | $53.4K | 4 |
| PHARMACEUTICAL DRUGS & MEDICINES CAPOMED (CAPTOPRIL 25 MG TABLET) | $50.0K | 7 |
| PHARMACEUTICALS DRUGS & MEDICINES "SATCAPTO-25 (CAPTOPRIL TABLETS USP 25 MG)"(AS PER INVOICE) | $50.0K | 1 |
| PHARMACEUTICALS DRUGS MEDICINES SATCAPTO 25 CAPTOPRIL TABLETS USP 25 MG ASPER INVOICE | $32.3K | 1 |
| PHARMACEUTICALS DRUGS & MEDICINES SATCAPTO-25 (CAPTOPRIL TABLETS USP 25 MG) (ASPER INVOICE)TBS | $26.8K | 3 |
| PHARMACEUTICAL DRUGS & MEDICINES CAPOMED (CAPTOPRIL 25 MG TABLET) | $5.0K | 3 |
| PHARMACEUTICALS DRUGS MEDICINES CAPTO 50 CAPTOPRIL TABLETS USP 50 MG AS PERINVOICE | $2.3K | 1 |
| PHARMACEUTICAL DRUGS & MEDICINES CAPTO-25 (CAPTOPRIL TABLETS USP 25 MG) | $1.5K | 1 |
| PHARMACEUTICAL DRUGS MEDICINES CPC CAPTOPRIL CAPTOPRIL TABLETS USP 25 MG ASPER INVOICE | $477 | 1 |
Stallion Laboratories Pvt Ltd exports 9 distinct Captopril formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICALS DRUGS & MEDICINES SATCAPTO-25 (CAPTOPRIL TAB with 4 shipments worth $53.4K.
Regulatory Requirements: Exporting Captopril to Key Markets
What Stallion Laboratories Pvt Ltd must comply with to export Captopril to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Stallion Laboratories Pvt Ltd Compare to Nearest Captopril Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | BIOMATRIX HEALTHCARE PRIVATE LIMITED | $243.8K | 10 | 5 | $24.4K |
| 5 | TORRENT PHARMACEUTICALS LTD | $235.9K | 35 | 4 | $6.7K |
| 6 | STALLION LABORATORIES PVT LTD ★ | $189.4K | 19 | 3 | $10.0K |
| 7 | MEDWISE OVERSEAS PRIVATE LIMITED | $163.7K | 6 | 1 | $27.3K |
| 8 | LINCOLN PHARMACEUTICALS LIMITED | $138.6K | 6 | 2 | $23.1K |
Stallion Laboratories Pvt Ltd ranks #6 among 109 Indian Captopril exporters. Average shipment value of $10.0K compared to the market average of $40.9K. The closest competitors by value are BIOMATRIX HEALTHCARE PRIVATE LIMITED and TORRENT PHARMACEUTICALS LTD.
Which Indian Ports Ship Captopril Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 96 | 18.6% |
| JNPT/ NHAVA SHEVA SEA | 42 | 8.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 35 | 6.8% |
| JNPT | 28 | 5.4% |
| AHEMDABAD ICD | 26 | 5.0% |
| SAHAR AIR | 25 | 4.8% |
| Jnpt | 18 | 3.5% |
| PATLI ICD | 18 | 3.5% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Captopril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Captopril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Stallion Laboratories Pvt Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 22 individual customs records matching Stallion Laboratories Pvt Ltd exporting Captopril, covering 9 formulations to 4 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 63+ countries, 170+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Captopril Export Data from Stallion Laboratories Pvt Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Stallion Laboratories Pvt Ltd's Captopril exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Stallion Laboratories Pvt Ltd
Company Profile
0 products · $0 total trade · 0 categories
Captopril Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Stallion Laboratories Pvt Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Captopril. For current shipment-level data, contact TransData Nexus.